TY  - GEN
AU  - Orefice,Nicola S
AU  - Alhouayek,Mireille
AU  - Carotenuto,Antonio
AU  - Montella,Silvana
AU  - Barbato,Franscesco
AU  - Comelli,Albert
AU  - Calignano,Antonio
AU  - Muccioli,Giulio G
AU  - Orefice,Giuseppe
TI  - Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis
SN  - 1878-7479
PY  - 2017///0116
KW  - Administration, Oral
KW  - Adult
KW  - Amides
KW  - Anti-Inflammatory Agents
KW  - administration & dosage
KW  - Cytokines
KW  - blood
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Ethanolamines
KW  - Female
KW  - Humans
KW  - Interferon beta-1a
KW  - adverse effects
KW  - Interferon-gamma
KW  - Interleukin-17
KW  - Male
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Palmitic Acids
KW  - Skin
KW  - drug effects
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s13311-016-0420-z
ER  -